The independent platform for news, articles and advice for professionals in laboratory medicine

Earlier cancer diagnosis with non-invasive serological testing for H. pylori

Endoscopy is considered the ‘gold standard’ method for investigating dyspeptic symptoms caused by Helicobacter pylori. Professor Peter Malfertheiner discusses the advantages offered by non-invasive ‘serological biopsy’ in the gastric cancer care pathway and management of atrophic gastritis.

Atrophic gastritis (AG) is a chronic condition that develops when the gastric mucosa is inflamed for a significant period of time, ultimately leading to irreversible loss of gastric gland function. In cases with severe chronic atrophic gastritis, the pre-neoplastic condition progresses to gastric cancer in approximately 10 per cent of patients within 10 years of diagnosis.1,2 This disease is the fifth most common cancer, and is responsible for the fourth-highest number of cancer-related deaths in the world,3 often due to a late diagnosis and lack of screening programme. It is therefore crucial to investigate high-risk patients as early as possible. 

There may be a number of causes for chronic AG, but bacterial infection in the stomach lining by Helicobacter pylori has been identified as one of the main culprits. This Gram-negative bacterium is actually relatively common, and it is predicted that more than half of the world’s population has H. pylori infection,4 with the majority of people going on to live healthy, symptom-free lives. 

However, in some cases, H. pylori infection can lead to far more sinister consequences, by disrupting the mucus barrier that helps to protect the stomach lining from the acidic juices that aid digestion. In some infected individuals, the damaging effect of the bacterium leads to the thinning of the mucosa and a loss of normal antral and oxyntic gland function, as gastric glandular cells are replaced by non-functioning intestinal-like epithelium and fibrous tissue.1 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.
Register

Upcoming Events

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025